Biogen Inc. Q2 2024 Earnings Overview
Thursday, 1 August 2024, 12:15
Biogen Inc. Q2 2024 Earnings
Biogen Inc. (NASDAQ: BIIB) has announced its earnings for the second quarter of 2024. Below are the key financial metrics:
Key Financial Highlights
- Total Revenue: $2.5 billion (flat at actual currency)
- Constant Currency Growth: Up 1% year-over-year
- Net Income: $583.6 million
- Comparison: Down from $591.6 million last year
- GAAP EPS: Declined by 2%
Conclusion
Biogen's second quarter financial performance signals ongoing challenges in the competitive biopharmaceutical landscape. As revenues showed little growth and earnings dipped, the company will need to focus on future strategies to enhance its market position.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.